Umbilical Blood Levels of IL-6 and TNF-α as Predictors of the Central Nervous System Damage and Retinopathy in Preterm Infants

Abstract

Objective The aim was to identify the critical levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor-A in umbilical cord blood that could be used as markers for predicting the central nervous system (CNS) damage and retinopathy of prematurity (ROP) in preterm infants.

Study Design A total of 158 preterm infants, born at 22 to 34 weeks of gestation, were evaluated in the first week after birth and at 36 to 37 weeks of postconceptual age.

Results A significant relationship between CNS changes and concentrations of IL-6 (p < 0.001) and TNF-α (p < 0.001) in umbilical cord blood at 22 to 34 weeks of gestation was determined. The concentration of IL-6 >13.0 pg/mL predicts significant CNS damages in 36 to 37-week infants (p = 0.013). ROP was diagnosed in 24.8% infants (n = 149). It was detected that the levels of TNF-α >116.4 pg/mL (p < 0.001) and IL-6 >13.0 pg/mL (p < 0.05) in umbilical cord blood could predict 2 to 3/3 to 4 stages of ROP.

Conclusion Critical values of IL-6 and TNF-α in predicting ≥grade III intraventricular hemorrhage in the early adaptation and in predicting marked CNS damages and severe ROP stages in the later adaptation of preterm infants were determined.

Keywords

prematurity - cytokines - umbilical cord blood - intraventricular hemorrhage - retinopathy of prematurity

Publication History

Received: 23 July 2019

Accepted: 29 December 2019

Article published online:
12 February 2020

• References

• 1 Malaeb S, Dammann O. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol 2009; 24 (09) 1119-1126
• 2 Black RE, Cousens S, Johnson HL. et al; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375 (9730): 1969-1987
• 3 Pappas A, Kendrick DE, Shankaran S. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr 2014; 168 (02) 137-147
• 4 Boyle EM, Poulsen G, Field DJ. et al. Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study. BMJ 2012; 344: e896
• 5 Swamy GK, Ostbye T, Skjaerven R. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 2008; 299 (12) 1429-1436
• 6 Matthiesen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 2012; 67 (04) 334-340
• 7 Lockwood CJ, Murk WK, Kayisli UA. et al. Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis. Am J Pathol 2010; 177 (04) 1755-1764
• 8 Kuin RA, Vis JY, Mol BW. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients. Obstet Gynecol 2010; 115 (01) 186-187
• 9 Pilypienė I, Drazdienė N, Dumalakienė I. et al. The significance of fetal inflammatory response syndrome in early and later adaptation of premature infants. Arch Gynecol Obstet 2015; 291 (01) 67-72
• 10 Peirovifar A, Gharehbaghi MM, Gharabaghi PM, Sadeghi K. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity. Singapore Med J 2013; 54 (12) 709-712
• 11 Al-Abdullah AA, Kozak I. Toward better evidence: meta-analysis of vascular endothelial growth factor (VEGF) polymorphisms in retinopathy of prematurity. Saudi J Ophthalmol 2014; 28 (04) 251-252
• 12 Malik MA, Shukla S, Azad SV, Kaur J. Vascular endothelial growth factor (VEGF-634G/C) polymorphism and retinopathy of prematurity: a meta-analysis. Saudi J Ophthalmol 2014; 28 (04) 299-303
• 13 Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983; 103 (02) 273-277
• 14 International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123 (07) 991-999
• 15 McAdams RM, Juul SE. The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int 2012; 2012: 561494
• 16 Berger I, Peleg O, Ofek-Shlomai N. Inflammation and early brain injury in term and preterm infants. Isr Med Assoc J 2012; 14 (05) 318-323
• 17 Yuan T-M, Sun Y, Zhan C-Y, Yu H-M. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and toll-like receptor signaling. J Neuroimmunol 2010; 229 (1-2): 16-25
• 18 Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol 2009; 87 (04) 264-280
• 19 Liu J, Feng Z-C. Increased umbilical cord plasma interleukin-1 beta levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J Trop Pediatr 2010; 56 (03) 178-182
• 20 Adén U, Favrais G, Plaisant F. et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010; 24 (05) 747-758
• 21 Goepfert AR, Andrews WW, Carlo W. et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol 2004; 191 (04) 1375-1381
• 22 Bueter W, Dammann O, Leviton A. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res 2009; 66 (05) 487-494
• 23 Kuypers E, Ophelders D, Jellema RK, Kunzmann S, Gavilanes AW, Kramer BW. White matter injury following fetal inflammatory response syndrome induced by chorioamnionitis and fetal sepsis: lessons from experimental ovine models. Early Hum Dev 2012; 88 (12) 931-936
• 24 Pérez-Muñuzuri A, Fernández-Lorenzo JR, Couce-Pico ML, Blanco-Teijeiro MJ, Fraga-Bermúdez JM. Serum levels of IGF1 are a useful predictor of retinopathy of prematurity. Acta Paediatr 2010; 99 (04) 519-525
• 25 Woo SJ, Park KH, Jung HJ. et al. Effects of maternal and placental inflammation on retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2012; 250 (06) 915-923
• 26 Chen ML, Allred EN, Hecht JL. et al; ELGAN Study. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci 2011; 52 (10) 7052-7058
• 27 Li ML, Hsu SM, Chang YS. et al. Retinopathy of prematurity in southern Taiwan: a 10-year tertiary medical center study. J Formos Med Assoc 2013; 112 (08) 445-453
• 28 Chen M, Citil A, McCabe F. et al. Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology 2011; 99 (02) 125-132
• 29 Woo SJ, Park KH, Lee SY. et al. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. Invest Ophthalmol Vis Sci 2013; 54 (05) 3434-3439
• 30 Dammann O, Brinkhaus MJ, Bartels DB. et al. Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev 2009; 85 (05) 325-329
• 31 Sood BG, Madan A, Saha S. et al; NICHD neonatal research network. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 2010; 67 (04) 394-400
• 32 Costagliola C, Romano V, De Tollis M. et al. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm 2013; 2013: 629529
• 33 Chapouly C, Tadesse Argaw A, Horng S. et al. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. Brain 2015; 138 (Pt 6): 1548-1567
• 34 Yang D, Baumann JM, Sun YY. et al. Overexpression of vascular endothelial growth factor in the germinal matrix induces neurovascular proteases and intraventricular hemorrhage. Sci Transl Med 2013; 5 (193) 193ra90
• 35 McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008; 35 (04) 777-792 , vii
• 36 Yenice O, Cerman E, Ashour A. et al. Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retina 2013; 44 (06) 549-554
• 37 Hellgren G, Löfqvist C, Hård AL. et al. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity. Pediatr Res 2016; 79 (1-1): 70-75
• 38 Goswami B, Goyal M, Beri S, Garg R, Saili A, Jain A. Role of serum levels of vascular endothelial growth factor and its receptor in retinopathy of prematurity. Iran J Pediatr 2015; 25 (04) e2373
• 39 Zhu D, Chen C, Shi W. Variations of vascular endothelial growth factor and pigment epithelial-derived factor are related to the retinopathy of prematurity in human babies. West Indian Med J 2015; 65 (02) 251-255
• 40 Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246 (10) 1467-1475
• 41 Klufas MA, Chan RV. Intravitreal anti-VEGF therapy as a treatment for retinopathy of prematurity: what we know after 7 years. J Pediatr Ophthalmol Strabismus 2015; 52 (02) 77-84
• 42 Morin J, Luu TM, Superstein R. et al; Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network Investigators. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 2016; 137 (04) e20153218